Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Nathalie, Rochet"'
Autor:
Florian Olivier, Christophe Drouet, Olivier Marsan, Vincent Sarou-Kanian, Samah Rekima, Nadine Gautier, Franck Fayon, Sylvie Bonnamy, Nathalie Rochet
Publikováno v:
Journal of Functional Biomaterials, Vol 14, Iss 5, p 246 (2023)
Critical bone defect repair remains a major medical challenge. Developing biocompatible materials with bone-healing ability is a key field of research, and calcium-deficient apatites (CDA) are appealing bioactive candidates. We previously described a
Externí odkaz:
https://doaj.org/article/2a98ed7ac2f146c390c24e123c86d988
Autor:
Cécilia Colson, Pierre-Louis Batrow, Sebastian Dieckmann, Laura Contu, Christian H. Roux, Laurence Balas, Claire Vigor, Baptiste Fourmaux, Nadine Gautier, Nathalie Rochet, Nathalie Bernoud-Hubac, Thierry Durand, Dominique Langin, Martin Klingenspor, Ez-Zoubir Amri
Publikováno v:
Cells, Vol 12, Iss 3, p 446 (2023)
Obesity is a complex disease highly related to diet and lifestyle and is associated with low amount of thermogenic adipocytes. Therapeutics that regulate brown adipocyte recruitment and activity represent interesting strategies to fight overweight an
Externí odkaz:
https://doaj.org/article/7f11fa2e039647608c31a2d3a57a52e1
Autor:
Nathalie Arians, Meinhard Kieser, Laura Benner, Nathalie Rochet, Lars Schröder, Sonja Katayama, Klaus Herfarth, Kai Schubert, Andreas Schneeweiss, Christof Sohn, Katja Lindel, Jürgen Debus
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-10 (2019)
Abstract Background To assess late toxicity, quality of life and oncological outcome after consolidative whole abdominal radiotherapy (WART) following cytoreductive surgery and carboplatin/paclitaxel chemotherapy in high risk patients with advanced o
Externí odkaz:
https://doaj.org/article/48e64db10bca4792b0a72e532ea3e188
Publikováno v:
JOM. 74:837-846
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcb35ed4a5b9c5a8490e8be1ce6ac6de
https://doi.org/10.1007/s11837-021-05101-2
https://doi.org/10.1007/s11837-021-05101-2
Autor:
Marie-Caroline Le Bousse-Kerdilès, Jean-Jacques Lataillade, Alessandro M. Vannucchi, Marie-Françoise Bourgeade, Jean-Christophe Ianotto, Brigitte Dupriez, Thierry de Revel, Jean-Baptiste Souraud, Olivier Pierre-Louis, Emilie Henault, Patricia Albanese, Nathalie Rochet, Bernadette Guerton, Adrienne Anginot, Sandrine Schmutz, Rachel Golub, Frédéric Torossian, Lisa Pieri, Johanna Konopacki, Christophe Desterke, Christophe Martinaud
Hematopoiesis support by MSCs in LTBMC BFU-E, CFU-G, CFU-M and CFU-GM by PMF (n=3) and healthy donors (HD, n=3) expressed as number of colonies for 104 bone marrow mononuclear cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81917032014d0729983806b2a5a8934b
https://doi.org/10.1158/0008-5472.22410834.v1
https://doi.org/10.1158/0008-5472.22410834.v1
Autor:
Fabien Muselli, Lucas Mourgues, Nathalie Rochet, Marielle Nebout, Agnès Guerci, Els Verhoeyen, Adrien Krug, Laurence Legros, Jean-François Peyron, Didier Mary
Publikováno v:
Cancers
Volume 15
Issue 3
Pages: 995
Volume 15
Issue 3
Pages: 995
Background & aims: In CML, Leukemic Stem Cells (LSCs) that are insensitive to Tyrosine Kinase Inhibitors are responsible for leukemia maintenance and relapses upon TKI treatment arrest. We previously showed that downregulation of the BMI1 polycomb pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f86b5026396bd34d5bdd1fb71f98c37
Autor:
Cécilia Colson, Pierre-Louis Batrow, Nadine Gautier, Nathalie Rochet, Gérard Ailhaud, Franck Peiretti, Ez-Zoubir Amri
Publikováno v:
Cells, Vol 9, Iss 11, p 2433 (2020)
Thermogenic brown and brite adipocytes convert chemical energy from nutrients into heat. Therapeutics that regulate brown adipocyte recruitment and activity represent interesting strategies to control fat mass such as in obesity or cachexia. The pero
Externí odkaz:
https://doaj.org/article/f2956457bbd34751a84fa6d39dd9bba9
Publikováno v:
Journal of Biomedical Materials Research Part B: Applied Biomaterials
Journal of Biomedical Materials Research Part B: Applied Biomaterials, Wiley, 2021, ⟨10.1002/jbm.b.34986⟩
Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2021, ⟨10.1002/jbm.b.34986⟩
Journal of Biomedical Materials Research Part B: Applied Biomaterials, Wiley, 2021, ⟨10.1002/jbm.b.34986⟩
Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2021, ⟨10.1002/jbm.b.34986⟩
International audience; We have previously shown that activated carbon fiber cloth (ACC) either uncoated or coated with carbonated calcium-deficient hydroxyapatite (CDA), namely ACC and ACC/CDA, were biocompatible in vitro with human osteoblasts. Her
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcbb642a74c4f675da24e6df47c08da1
https://hal.archives-ouvertes.fr/hal-03474712
https://hal.archives-ouvertes.fr/hal-03474712
Autor:
Jean-Marie Guigonis, Jean-Michel Bouler, Lun Jing, Solène Rota, Michel Samson, Sébastien Schaub, Jean-Claude Scimeca, David Momier, Nathalie Rochet, Patricia Lagadec, Florian Olivier
Publikováno v:
Acta Biomaterialia
Acta Biomaterialia, 2021, 127, pp.298-312. ⟨10.1016/j.actbio.2021.03.070⟩
Acta Biomaterialia, Elsevier, 2021, 127, pp.298-312. ⟨10.1016/j.actbio.2021.03.070⟩
Acta Biomaterialia, 2021, 127, pp.298-312. ⟨10.1016/j.actbio.2021.03.070⟩
Acta Biomaterialia, Elsevier, 2021, 127, pp.298-312. ⟨10.1016/j.actbio.2021.03.070⟩
International audience; Immediately upon implantation, scaffolds for bone repair are exposed to the patient's blood. Blood proteins adhere to the biomaterial surface and the protein layer affects both blood cell functions and biomaterial bioactivity.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2cb801ad5854f31bd3ffa1707715706
https://hal.science/hal-03357728/document
https://hal.science/hal-03357728/document
Autor:
Nathalie Rochet, Robert M William, Marielle Nebout, Lucas Mourgues, Douglas V. Faller, Fabien Muselli, Rita Morcos, Laurence Legros, Els Verhoeyen, Rana Mhaidly, Jean-François Peyron, Didier Mary, Agnès Guerci-Bresler
Publikováno v:
Cancers
Volume 13
Issue 7
Cancers, Vol 13, Iss 1693, p 1693 (2021)
Volume 13
Issue 7
Cancers, Vol 13, Iss 1693, p 1693 (2021)
Simple Summary The tyrosine kinase inhibitor (TKI) imatinib was the first targeted therapy to show clinical efficacy against chronic myeloid leukemia (CML) through inhibition of the breakpoint cluster region–Abelson murine leukemia viral oncogene h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21fe7665b292484c82ea06dcf6a17659